KEY PRODUCTS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL
01 1Atorvastatin calcium
01 1Netherlands
01 1Valid
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Certificate Number : R1-CEP 2010-366 - Rev 06
Status : Valid
Issue Date : 2023-05-25
Type : Chemical
Substance Number : 2191
20
Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
One of their significant offerings is Atorvastatin calcium, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-366 - Rev 06
This Chemical Type CEP, issued on May 25, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2191 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
